Harnessing tumor-associated macrophages as aids for cancer immunotherapy
Xiaolei Li, Rui Liu, Xiao Su, Yongsha Pan, Xiaofeng Han, Changshun Shao, Yufang Shi
Read Harnessing tumor-associated macrophages as aids for cancer immunotherapy by Xiaolei Li, Rui Liu, Xiao Su, Yongsha Pan, Xiaofeng Han, Changshun Shao, Yufang Shi in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6894344.txt.
Description
Li and co-authors review ways to turn tumour macrophages into allies, in Molecular Cancer. Immunotherapy has become a powerful weapon, yet most solid tumours barely respond. Their local environment suppresses attack. Tumour-associated macrophages flood that environment. Left alone, they help the tumour grow, spread, and grow new vessels, while shielding it from immunity.
The review sorts strategies for flipping these cells: killing them off, blocking their recruitment, or reprogramming them to fight. Early attempts have shown effects across tumour types in lab and clinical studies. One older drug, trabectedin, turns out to kill such macrophages selectively through a death-receptor route. The authors argue macrophages should be treated as partners in immunotherapy design.
Catalog record
| CREATOR | Xiaolei Li, Rui Liu, Xiao Su, Yongsha Pan, Xiaofeng Han, Changshun Shao, Yufang Shi |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |